cAMP produced by pituitary adenylate cyclase-activating polypeptide 27 inhibits atrial natriuretic peptide secretion in rabbit beating atria

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 10, 2008, Pages 1233-1237

  Zhang, Ying ^a,b   Liu, Li Ping ^a   Liang, Zhe Long ^a   Li, Xiang Lan ^a   Jin, Yuan Zhe ^a   Cui, Xun ^a  

^a YANBIAN UNIVERSITY   (China)

^b Yanbian Red Cross Center Blood Station   (China)

Author keywords

Atrial natriuretic peptide; cAMP; L type Ca2+ channel; Pituitary adenylate cyclase activating polypeptide 27; Protein kinase

Indexed keywords

ADENYLATE CYCLASE; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL L TYPE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NICARDIPINE; STAUROSPORINE;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CHANNEL GATING; CONTROLLED STUDY; HEART ATRIUM CONTRACTION; HEART STROKE VOLUME; HORMONE ACTION; HORMONE RELEASE; NONHUMAN; PROTEIN FUNCTION; RABBIT; RADIOIMMUNOASSAY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE LEVEL;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CYCLIC AMP; HEART; HEART ATRIA; PERFUSION; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RABBITS; SIGNAL TRANSDUCTION;

EID: 50649108607     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.04996.x     Document Type: Article

References (33)

1. De Bold AJ. Atrial natriuretic factor: A hormone produced by the heart. Science 1985 230 : 767 70.
2. Dietz JR. Release of natriuretic factor from rat heart-lung preparation by atrial distension. Am. J. Physiol. 1984 247 : R1093 6.
3. Lang RE, Thoelken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor: A circulating hormone stimulated by volume loading. Nature 1985 314 : 264 6.
4. Cho KW, Kim SH, Hwang YH, Seul KH. Extracellular fluid translocation in perfused rabbit atria: Implication in control of atrial natriuretic peptide secretion. J. Physiol. 1993 468 : 591 607.
5. Lee SJ, Kim SZ, Cui X et al. C-Type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling. Am. J. Physiol. Heart Circ. Physiol. 2000 278 : H208 21.
6. Iida H, Page E. Inhibition of atrial natriuretic peptide secretion by forskolin in noncontracting cultured atrial myocytes. Biochem. Biophys. Res. Commun. 1988 157 : 330 6.
7. Shields PP, Glembotski CC. Regulation of atrial natriuretic factor-(99-126) secretion from neonatal rat primary atrial cultures by activators of protein kinase A and C. J. Biol. Chem. 1989 264 : 9322 8.
8. Muir TM, Hair J, Inglis GC, Dow JW, Lindop GB, Leckie BJ. Hormonal control of atrial natriuretic peptide synthesis and secretion from cultured atrial myocytes. J. Mol. Cell. Cardiol. 1993 25 : 509 18.
9. 2+-independent cAMP inhibition of ANP release in beating rabbit atria. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002 282 : R1477 89.
10. Ruskoaho H, Toth M, Ganten D, Unger Th, Lang RE. The phorbol ester induced atrial natriuretic peptide secretion is stimulated by forskolin and BAY K 8644 and inhibited by 8-bromo-cyclic GMP. Biochem. Biophys. Res. Commun. 1986 139 : 266 74.
11. Church DJ, Van der Bent V, Vallotton MB, Capponi AM, Lang U. Calcium influx in platelet activating factor-induced atrial natriuretic peptide release in rat cardiomyocytes. Am. J. Physiol. Endocrinol. Metab. 1994 266 : E1588 94.
12. Azizi C, Barthelemy C, Masson F, Maistre G, Eurin J, Carayon A. Myocardial production of prostaglandins: Its role in atrial natriuretic peptide release. Eur. J. Endocrinol. 1995 133 : 255 9.
13. Schiebinger RJ, Li Y, Cragoe Jr EJ. Calcium dependency of frequency-stimulated atrial natriuretic peptide secretion. Hypertension 1994 23 : 710 16.
14. Miyata Y, Arimura K, Dahl RR et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 1989 164 : 567 74.
15. Miyata A, Jiang L, Dahl RD et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commun. 1990 170 : 643 8.
16. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C. Tissue distribution of PACAP as determined by RIA. Highly abundant in the rat brain and testes. Endocrinology 1991 129 : 2787 9.
17. Sreedharan SP, Huang JX, Cheung MC, Goetzl EJ. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc. Natl Acad. Sci. USA 1995 92 : 2939 43.
18. Wei Y, Mojsov S. Multiple human receptors for pituitary adenylly cyclase-activating polypeptide and vasoactive intestinal peptide are expressed in a tissue-specific manner. Ann. N.Y. Acad. Sci. 1996 805 : 624 7.
19. Ross-Ascuitto NT, Ascuitto RJ, Ramage D, Kydon DW, Coy DH, Kadowitz PJ. Pituitary adenylate cyclase activating polypeptide: A neuropeptide with potent inotropic and coronary vasodilatory effects in neonatal pig hearts. Pediatr. Res. 1993 34 : 323 8.
20. Ascuitto RJ, Ross-Ascuitto NT, Waddell AE, Kadowitz PJ. Contractile and coronary vascular effects of pituitary adenylate cyclase activating polypeptide in neonatal pig hearts. Cardiovasc. Res. 1996 31 : E153 9.
21. Yonezawa T, Furukawa Y, Lakhe M, Nagashima Y, Hirose M, Chiba S. PACAP-38 activates parasympathetic nerves in isolated, blood-perfused dog atria. Eur. J. Pharmacol. 1996 315 : 289 96.
22. Hirose M, Furukawa Y, Nagashima Y, Lakhe M, Miyashita Y, Chiba S. PACAP-27 causes negative and positive dromotropic effects in anesthetized dogs. Eur. J. Pharmacol. 1997 338 : 35 42.
23. Suzuki Y, Kasai K, Takekoshi K et al. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the cardiovascular system. Regul. Pept. 1993 47 : 213 20.
24. Cui X, Lee SJ, Kim SZ, Kim SH, Cho KW. Effects of pituitary adenylate cyclase activating polypeptide 27 on cyclic AMP efflux and atrial dynamics in perfused beating atria. Eur. J. Pharmacol. 2000 402 : 129 37.
25. Cho KW, Kim SH, Kim CH, Seul KH. Mechanical basis of atrial natriuretic peptide secretion in beating atria. Atrial stroke volume and ECF translocation. Am. J. Physiol. 1995 268 : R1129 36.
26. Steiner AL, Parker CW, Kipnis DM. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J. Biol. Chem. 1972 247 : 1106 13.
27. Basler I, Kuhn M, Forssmann WG. Pituitary adenylate cyclase-activating polypeptide stimulates cardiodilatin/atrial natriuretic peptide (CDD/ANP-(99-126) secretion from cultured neonatal rat myocardiocytes. Eur. J. Pharmacol. 1995 291 : 335 42.
28. 2 receptor-cAMP-protein kinase signaling. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003 285 : 380 93.
29. 2+ current regulation in cardiac cells. Life Sci. 1991 48 : 2365 76.
30. 2+ channels in regulation of atrial ANP release. Am. J. Physiol. Heart Circ. Physiol. 2000 279 : H2879 88.
31. Rebsamen MC, Church DJ, Morabito D, Vallotton MB, Lang U. Role of cAMP and calcium influx in endothelin-1-induced ANP release in rat cardiomyocytes. Am. J. Physiol. 1997 273 : E922 31.
32. Taskinen P, Toth M, Vuolteenaho O, Magga J, Ruskoaho H. Inhibition of atrial wall stretch-induced cardiac hormone secretion by lavendustin A, a potent tyrosine kinase inhibitor. Endocrinology 1999 140 : 4198 207.
33. Han JH, Cao CH, Kim SZ, Cho KW, Kim SH. Decreases in ANP secretion by lysophosphatidylcholine through protein kinase C. Hypertension 2003 41 : 1380 5.